Skip to main content
OpenTrials
Completed

NCT Number: NCT02502630

Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

(MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate CT-guided percutaneous microwave (MW) ablation safety and efficacy in pulmonary metastases from colorectal cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colorectal Cancer Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

From June 2010 to June 2015, 48 unresectable lesions in 32 patients with pulmonary metastases from colorectal cancer were selected for CT-guided microwave ablation. Patients were scheduled for a 1 and 3 month CT follow-up to evaluate lesion diameter.We retrospectively evaluated CT-guided percutaneous microwave (MW) ablation safety and efficacy in pulmonary metastases from colorectal cancer.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unresectable pulmonary metastases from colorectal cancer.
  • diagnosis by CT, and confirmed by percutaneous puncture biopsy.
  • Age range 18-70 years old.
  • Eastern Cooperative Oncology Group performance status 0-1.
  • Life expectancy of more than 3 months.
  • Adequate organ function.

Exclusion criteria

  • Resectable lung metastases.
  • Life expectancy less than 3 months
  • Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic instruments or other metal materials.
  • Coagulopathy with platelet count less than 50000.
  • Active infectious disease.
  • Age below 18 years.
  • Pregnancy of breastfeeding.

Treatment and study plan

microwave ablation

Device

pulmonary metastases from colorectal cancer are destructed/ablated using microwave ablation

Primary outcomes

  1. Overall Survival (OS)

    Time frame: one year

Secondary outcomes

  1. Treatment related adverse events

    Time frame: Eight weeks

Sponsors and collaborators

Lead sponsor

The First People's Hospital of Changzhou

Other

Registry information

Official study title

CT-guided Percutaneous Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

Important dates

Study start
2010
Primary completion
2015
Study completion
2015
First posted
Jul 20, 2015
Registry last updated
Aug 15, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.